I.
REFERENCES
A.
Systemwide
Business and Finance Bulletin (B&FB), BUS-50: Acquisition and Use of
Narcotics and Dangerous Drugs.
B.
Public
Law 91-513, Comprehensive Drug Abuse Prevention and Control Act of 1970,
referred to as Federal Controlled Substances Act.
C.
Regulations
Implementing the Comprehensive Drug Abuse Prevention and Control Act of 1970.
21 CFR, Chapter II, Drug Enforcement Administration, Department of Justice.
D.
California
Uniform Controlled Substances Act, Division 10 of the California Health and
Safety Code.
E.
Letter
of August 14, 1972, from Vice President McCorkle to Chancellors and Laboratory
Directors: Delegation of Authority—Registration and Acquisition of Narcotics
and Dangerous Drugs.
F.
Letter
of September 2, 1981, from President Saxon to Chancellors and Others:
University Policy on the Protection of Human Subjects in Research.
G.
Letter
of September 2, 1981, from President Saxon to Vice President Frazer: Delegation
of Authority --Protection of Human Subjects in Research.
H.
Annual
Reports of the California Research Advisory Panel.
I.
Letter
of December 15, 1986, from Chancellor Richard C. Atkinson to Vice Chancellor
Steven W. Relyea, Business Affairs: Delegation of Authority—Registration &
Acquisition of Narcotics & Dangerous Drugs.
J.
Letter
of April 3, 2006, from Senior Vice President Joseph P. Mullinix to Vice
Chancellor Steven W. Relyea, Business Affairs: Approval of Policy Exception
Request for the Management of Controlled Substances for Non-Clinical Research.
K. Letter of October 11, 2006, from Vice
Chancellor Steven W. Relyea, Business Affairs: Delegation of Authority –
Controlled Substances Program Manager.
II.
SCOPE
This
policy sets forth requirements and procedures applicable to the authorization,
procurement, receipt, security, storage, control, biennial inventory, and
disposal of Controlled Substances, List I and Precursor Chemicals for research,
teaching and veterinary care. This policy does not apply to controlled
substances dispensed by a practitioner to a patient in the course of
professional practice as authorized by his/her license, procurement or use for
human care on ocean vessels, nor to licensed UCSD pharmacies. Oversight for
controlled substances research involving most human subject research is the
responsibility of the UC San Diego Health Sciences Office of Compliance &
Privacy (OCP) and the Department of Pharmacy, and is not covered by this
policy.
III.
DEFINITIONS
A.
Controlled
Substance
A
controlled substance is
a drug or chemical substance whose possession and use are regulated under the
Federal Controlled Substances Act and California Uniform Controlled Substances
Act. For purposes of this document, controlled substance policies and
procedures shall also apply to control of List I and Precursor chemicals.
B.
Schedules
of Controlled Substances
Controlled
substance schedules are classifications of narcotics and dangerous drugs,
ranked according to their potential for abuse and other relevant factors, and
are denoted by Roman numerals I through V. Schedules were established by Public
Law 91-513, the Comprehensive Drug Abuse Prevention Act of 1970 (1980
Revision), in order to provide clear guidelines for the implementation of
controls on the manufacture and procurement of controlled substances.
Information concerning the assignment of particular substances to specific
schedules may be obtained at http://blink.ucsd.edu/go/cs
or by calling the Controlled
Substances Program Manager in the Environment, Health and Safety Department
(EH&S).
C.
Listed
Chemicals
Listed
chemicals are chemicals of concern that can be used to make a controlled
substance and were established by Public Law 103-200, the Domestic Chemical Diversion
Control Act of 1993. There are two lists, List I and List II, though for the
purposes of this document only List I chemicals are referenced. These lists
can be obtained at http://blink.ucsd.edu/go/cs .
D.
Precursor
Chemicals
Precursor
Chemicals, as used in this policy, are any substance listed under California
Health and Safety Code sec. 11100 et seq. This list of chemicals can be
obtained at http://blink.ucsd.edu/go/cs.
E.
Purposes
Covered by this Policy
Animal
research, clinical research, teaching, veterinary care, and in-vitro
(non-animal) research are covered by this policy. This policy does not cover
research conducted with controlled substances acquired from a campus pharmacy.
F.
Projects
Projects
shall include an actual research project or a teaching or veterinary purpose.
G.
Department
Chair
A
Department Chair shall include faculty appointed as Department Chair or Section
Chair.
H.
Principal
Investigator
A
Principal Investigator includes “In Residence,” “Adjunct” and “Clinical”
Professors, Associate Professors, Assistant Professors, Instructors,
Professors, and Veterinarians who are assigned space for research or teaching
activities. A faculty member without assigned space may be considered Principal
Investigator upon approval of their Department Chair.
I.
Authorized
Personnel
Authorized
personnel are faculty, staff, students, or visiting scholars who have a
need to handle or access controlled substances for Department-approved projects
at UCSD. The number of Authorized Personnel shall be kept to a minimum in order
to maintain security. In order to become an Authorized Personnel, the
individual must sign the Controlled Substance Personnel Screening Data Sheet
(PSDS), indicate no prior history with controlled substance abuse or diversion,
obtain Principal Investigator signature authorization, file a copy with
EH&S, and subsequently file for addition to the Controlled Substances Use
Authorization (CSUA).
IV.
POLICY
A.
Regulatory
Compliance
UCSD
shall comply with all applicable Federal and State Laws and regulations
governing controlled substances. All controlled substance policies and
procedures shall apply to control of List I and Precursor chemicals as well.
B.
Registration
Authority
to possess or dispense controlled substances for research, teaching, and
veterinary care purposes shall be requested from the U.S. Department of
Justice, Drug Enforcement Administration (DEA). All projects involved in the
possession or use of controlled substances II-V shall be covered under an applicable
University registration.
Registration
for Controlled Substances in Schedules II-V shall be held in the name of the
academic department per geographical location and activity and coordinated by the
Controlled Substances Program Manager. If an operation remote from the campus
requires controlled substances, a separate registration is necessary for each
type of activity involved.
Registration
for Controlled Substances in Schedule I shall be obtained and managed by the
Principal Investigator per geographical location and activity. This
registration is not transferable.
C.
Approval
of Projects
Use
of controlled substances under university registrations is restricted to
projects where such use has been specifically authorized by the appropriate
Department Chair as declared on the CSUA. In his/her absence, this may be
delegated to one individual of a comparable level of authority. In these
instances, this individual would be delegated the authority to sign as a
Department Chair Alternate. Department Chairs requiring CSUA(s) for their own
projects must acquire authorization from their Dean or an individual of a
comparable level.
Projects
must be written to satisfy specific DEA requirements. An approved Institutional
Animal Care and Use Program(IACUC)
research protocol shall be sufficient project documentation for animal research
projects. An approved Human Subjects Institutional Review Board protocol shall
be sufficient documentation for human clinical research.
Additional
approval for any project which proposes to use a Schedule I controlled
substance, any human research involving a Schedule I or II controlled
substance, or research for treatment of drug abuse using any drug (scheduled or
not) must be reviewed simultaneously by the State of California Research
Advisory Panel prior to commencement of work.
D.
Orders
for Controlled Substances
The
Department Chair or Principal Investigator must determine the need for and sign
all requisitions for Controlled Substances, regardless of dollar value. Purchase
requests shall be submitted to the Controlled Substances Program Manager of
EH&S for review. Approved requisitions will be forwarded by EH&S to
the Purchasing Department in Business and Financial Services for order
placement. All purchases of such materials using university-controlled funds
shall be made only by Purchasing. No orders may be placed by departmental
personnel directly with vendors.
E.
Penalties
for Non-Compliance
Possible
penalties for violating DEA regulations include rescission of the university
registrations authorizing the use of controlled substances, imposition of
fines, and imprisonment of those responsible. Possible penalties for violations
of this policy include CSUA revocation, repossession of all controlled
substances in inventory, suspension of purchase requisition authorization, and suspension
or termination of Authorized Personnel privileges.
V.
RESPONSIBILITY
A.
Environment,
Health and Safety
The
Controlled Substances Program Manager maintains delegated authority and
responsibility for overall coordination of this policy and specific
responsibility for the approval, receipt, and delivery of controlled substances
to authorized personnel. EH&S is also responsible for disposal of
controlled substances, biennial inventory notification to the Department Chair
and/or designated Principal Investigator for inventory of controlled
substances, authorizing the storage location approval process, and for
approving all
storage
locations. The Controlled Substances Program Manager is responsible for
obtaining and maintaining any powers of attorney required for program operation
within EH&S. The above information shall be available to the DEA upon
request. The Controlled Substances Program Manager shall perform announced and
unannounced audits to measure compliance with these policies.
EH&S
is responsible for maintaining a central storage and pick-up area for receiving
incoming shipments at each of the main registered locations (Hillcrest, La
Jolla, and Elliott Field), for obtaining appropriate signatures of persons
authorized to receive controlled substances, and compliance monitoring by
regular audits.
B.
Department
1.
The
Department Chair is assigned responsibility for approving projects involving
the use of controlled substances by departmental personnel, for authorizing
faculty as Principal Investigators, for notifying EH&S if a new Principal
Investigator arrives on campus with controlled substances, for notifying
EH&S when a Principal Investigator authorized to experiment with controlled
substances dies or intends to terminate employment, and for preparation of such
reports as may be required. Department approval is granted by Chair's signature
on each Principal Investigator's CSUA application for one year and may be
renewed.
2.
The
Department Chair is responsible for assuring that a current inventory of all
controlled substances under his/her control is maintained by the Principal
Investigator on the Controlled Substances Log Sheet in a separate, secure book
for periodic audit by EH&S and/or the DEA.
3.
The
Department Chair and the Principal Investigator are assigned joint
responsibility for determining the need for and signing (authorizing) all
requisitions for controlled substances. The Principal Investigator is assigned
primary responsibility for assuring that a current inventory of all controlled
substances under his/her control is maintained, that inventory forms are
submitted upon notification by and at the request of EH&S, that a current
CSUA is on file with EH&S, ensuring that a list is maintained of those
individuals handling controlled substances in the laboratory, and that all DEA
security regulations are being followed.
4.
The
Department Chair and/or Principal Investigator is assigned responsibility for
the preparation and submission of Research Protocol and all information
required for Schedule I controlled substances.
5.
The
Principal Investigator is assigned responsibility for assigning and authorizing
laboratory personnel to handle controlled substances. Each proposed laboratory
personnel to handle controlled substances must fill out a Personnel Screening
Data Sheet (PSDS). The PSDS shall be sent to the Controlled Substances Program
Manager for review in order to become an Authorized Personnel. If an applicant
has a criminal history of mishandling controlled substances, he or she shall
not be granted access to the Principal Investigator's controlled substances.
C.
Materiel
Management
The
Materiel Manager is assigned administrative responsibility for the purchase and
return of controlled substances to the original vendor/supplier in coordination
with EH&S. Authority to sign University Purchase Orders for controlled
substances is restricted to authorized persons in the Purchasing Department in
Business and Financial Services. This information shall be available to the
DEA upon request.
D.
Police
Department
The
University Police Department investigates all suspected thefts or misuse of controlled
substances.
VI.
REQUIREMENTS
OF OTHER AGENCIES
If approval of any other federal or state
agency is required for the use of any controlled substance, application for
such approval shall be filed by the Principal Investigator and evidence of
approval submitted to the Controlled Substances Program Manager.
VII.
REVISION HISTORY
10/06/2022 Policy scope updated.